Can brain signals and anatomy refine contact choice for deep brain stimulation in Parkinson's disease?
- PMID: 35589375
- DOI: 10.1136/jnnp-2021-327708
Can brain signals and anatomy refine contact choice for deep brain stimulation in Parkinson's disease?
Abstract
Introduction: Selecting the ideal contact to apply subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease is time-consuming and reliant on clinical expertise. The aim of this cohort study was to assess whether neuronal signals (beta oscillations and evoked resonant neural activity (ERNA)), and the anatomical location of electrodes, can predict the contacts selected by long-term, expert-clinician programming of STN-DBS.
Methods: We evaluated 92 hemispheres of 47 patients with Parkinson's disease receiving chronic monopolar and bipolar STN-DBS. At each contact, beta oscillations and ERNA were recorded intraoperatively, and anatomical locations were assessed. How these factors, alone and in combination, predicted the contacts clinically selected for chronic deep brain stimulation at 6 months postoperatively was evaluated using a simple-ranking method and machine learning algorithms.
Results: The probability that each factor individually predicted the clinician-chosen contact was as follows: ERNA 80%, anatomy 67%, beta oscillations 50%. ERNA performed significantly better than anatomy and beta oscillations. Combining neuronal signal and anatomical data did not improve predictive performance.
Conclusion: This work supports the development of probability-based algorithms using neuronal signals and anatomical data to assist programming of deep brain stimulation.
Keywords: ELECTRICAL STIMULATION; EVOKED POTENTIALS; NEUROPHYSIOLOGY; NEUROSURGERY; PARKINSON'S DISEASE.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: SSX holds options in DBS Technologies Pty Ltd. W-LL has no relevant financial disclosures. TP receives consulting fees and holds options in DBS Technologies Pty Ltd and is a named inventor on related patents, which are assigned to DBS Technologies Pty Ltd. NCS is a named inventor on related patents, which are assigned to DBS Technologies Pty Ltd. KJB, HJM and WT are co-founders and hold shares and options in DBS Technologies Pty Ltd which plans to commercialise the use of neuronal signals to improve DBS. KJB, HJM and WT are also named inventors on related patents, which are assigned to DBS Technologies Pty Ltd.
LinkOut - more resources
Full Text Sources